Safety and Tolerability of GX-G6 in Healthy Male Subjects

Summary

This study is a single-center, double-blind, placebo-controlled, phase I study with healthy male subjects receiving ascending single s.c. doses of GX-G6

Timeline

Start

2017-08-31

Primary completion

2018-06-06

Completion

2018-06-28

Drugs

Indications